Pharm
Apomorphine
search
Apomorphine
, Apokyn, Uprima, Kynmobi, Zydis
See Also
Dopamine Agonist
Parkinsonism
Erectile Dysfunction
Indications
Parkinsonism
Hypomobility episodes (rescue)
Erectile Dysfunction
Effective in 55 to 60% of men (contrast 32% in
Placebo
)
Precautions
Never use IV (high risk of cardiovascular complications)
Mechanism
Central acting,
Non-ergot Dopamine Agonist
Pharmacokinetics
Sublingual (Uprima)
Onset: 10 minutes
Duration: 30 minutes
Dosing
Parkinsonism
- Acute hypomobility ("Off" Episode or severe "freezing" episode)
Preparations
Administered by Apokyn injector pen (10 mg/ml)
Apomorphine Sublingual Film (Kynmobi) is also available
However, intolerable due to oropharyngeal adverse effects in a third of patients
First test dose (observed by clinician): 0.2 ml SQ
Reduce starting dose to 0.1 ml in mild to moderate renal disease
May try higher test dose if ineffective
Monitor for
Orthostatic Hypotension
If test dose effective and tolerated
May increase by 0.1 ml/dose every few days as needed
Rotate injection sites
Monitor for
Orthostatic Hypotension
Typical frequency: three times daily as needed for Acute hypomobility ("Off" Episode)
Maximum: 0.6 ml/dose (or 2 ml/day)
Duration: Avoid use longer than 2 months
Pretreat dose with
Antiemetic
(
Nausea
and
Vomiting
is very common)
Start
Antiemetic
three days prior to initiating Apomorphine
Do NOT combine with
5-HT3 Antagonist
s (e.g.
Ondansetron
) due to risk of
Hypotension
,
Syncope
Trimethobenzamide
(
Tigan
) 300 mg orally three times daily
Dosing
Erectile Dysfunction
Uprima 2 to 6 mg SL prn
Adverse Effects
Erectile Dysfunction
(Sublingual Uprima, Zydis)
Adverse effects seen in 58% of men on 6 mg
Nausea
(39%) and
Vomiting
(10%)
Due to
Dopamine
rgic stimulation at the
Chemoreceptor
Trigger Zone
(CMZ) in
Medulla
Dizziness
(20%)
Somnolence
(11%)
Sweaty (18%)
Hypotension
(4%)
Syncope
(2%)
Resources
Apomorphine (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3235535d-9ef9-4657-8b2a-176a807d091c
References
(2021) Med Lett Drugs Ther 63(1618): 25-32
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here